Moderate (2%, v/v) Ethanol Feeding Alters Hepatic Wound Healing after Acute Carbon Tetrachloride Exposure in Mice.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 26751492)

Published in Biomolecules on January 06, 2016

Authors

Krutika T Deshpande1,2, Shinlan Liu3,4, Jennifer M McCracken5,6, Lu Jiang7,8, Ta Ehpaw Gaw9,10, Lindsey N Kaydo11, Zachary C Richard12, Maura F O'Neil13,14, Michele T Pritchard15,16

Author Affiliations

1: Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA. kdeshpande@outlook.com.
2: Department of Pathology, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA. kdeshpande@outlook.com.
3: Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA. jawahal@hotmail.com.
4: Department of Pathology, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA. jawahal@hotmail.com.
5: Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA. jmccracken2@kumc.edu.
6: Department of Pathology, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA. jmccracken2@kumc.edu.
7: Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA. ljiang@kumc.edu.
8: Department of Pathology, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA. ljiang@kumc.edu.
9: Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA. tagaw75@gmail.com.
10: Department of Pathology, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA. tagaw75@gmail.com.
11: Department of Gastroenterology and Hepatology, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106, USA. lxk176@case.edu.
12: Department of Gastroenterology and Hepatology, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106, USA. zrichar1@nd.edu.
13: Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA. moneil@kumc.edu.
14: Department of Pathology, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA. moneil@kumc.edu.
15: Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA. mpritchard@kumc.edu.
16: Department of Pathology, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA. mpritchard@kumc.edu.

Articles cited by this

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev (2008) 10.28

Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev (1993) 8.03

A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res (2003) 6.76

Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science (1996) 6.70

Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol (2004) 6.36

Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci (2004) 5.59

Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol (2007) 5.16

Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology (2011) 5.06

PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res (2009) 5.03

Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A (1997) 4.33

Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol (2003) 4.25

Cellular and molecular basis of wound healing in diabetes. J Clin Invest (2007) 4.22

CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med (2007) 2.93

Origin and functions of tissue macrophages. Immunity (2014) 2.63

Evolving therapies for liver fibrosis. J Clin Invest (2013) 2.59

Role of oxidative stress in alcohol-induced liver injury. Arch Toxicol (2009) 2.45

The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med (2003) 2.38

A comprehensive collection of experimentally validated primers for Polymerase Chain Reaction quantitation of murine transcript abundance. BMC Genomics (2008) 2.07

Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol (2003) 2.02

Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. Hepatology (1998) 1.96

Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology (2007) 1.75

Cyclin E. Int J Biochem Cell Biol (2004) 1.64

Macrophage heterogeneity in liver injury and fibrosis. J Hepatol (2014) 1.63

Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology (1998) 1.60

An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice. Hepatology (2009) 1.60

Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Alcohol Clin Exp Res (2008) 1.55

Tissue repair: an important determinant of final outcome of toxicant-induced injury. Toxicol Pathol (2005) 1.50

Macrophage plasticity and polarization in liver homeostasis and pathology. Hepatology (2014) 1.48

Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am J Pathol (1998) 1.45

Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack CYP2E1 expression. Toxicol Appl Pharmacol (1998) 1.39

Depressed liver regeneration after partial hepatectomy of germ-free, athymic and lipopolysaccharide-resistant mice. Hepatology (1990) 1.36

Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride. Am J Pathol (1998) 1.27

Inhibition of hepatic regeneration in rats by acute and chronic ethanol intoxication. Gastroenterology (1979) 1.24

Ethanol induces redox-sensitive cell-cycle inhibitors and inhibits liver regeneration after partial hepatectomy. Alcohol Clin Exp Res (2002) 1.22

Cyclins A and B1 in the human cell cycle. Ciba Found Symp (1992) 1.18

Animals models of gastrointestinal and liver diseases. Animal models of alcohol-induced liver disease: pathophysiology, translational relevance, and challenges. Am J Physiol Gastrointest Liver Physiol (2014) 1.11

Early growth response-1 attenuates liver injury and promotes hepatoprotection after carbon tetrachloride exposure in mice. J Hepatol (2010) 1.10

Inhibition of apoptosis protects mice from ethanol-mediated acceleration of early markers of CCl4 -induced fibrosis but not steatosis or inflammation. Alcohol Clin Exp Res (2012) 1.10

Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver. Gen Pharmacol (1997) 1.09

Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning. Hepatology (2003) 1.06

Signaling pathways that control cell proliferation. Cold Spring Harb Perspect Biol (2013) 1.05

Macrophages: central regulators of hepatic fibrogenesis and fibrosis resolution. J Hepatol (2012) 1.04

Molecular therapy for hepatic injury and fibrosis: where are we? World J Gastroenterol (2006) 1.01

Hepatic fibrosis is enhanced and accompanied by robust oval cell activation after chronic carbon tetrachloride administration to Egr-1-deficient mice. Am J Pathol (2010) 1.00

Ethanol and hormesis. Crit Rev Toxicol (2003) 0.97

Adenosine 2A receptor antagonist prevented and reversed liver fibrosis in a mouse model of ethanol-exacerbated liver fibrosis. PLoS One (2013) 0.95

Fibrosis in alcoholic and nonalcoholic steatohepatitis. Best Pract Res Clin Gastroenterol (2011) 0.94

Early growth response (EGR)-1 is required for timely cell-cycle entry and progression in hepatocytes after acute carbon tetrachloride exposure in mice. Am J Physiol Gastrointest Liver Physiol (2011) 0.93

Hepatocyte proliferation is the possible mechanism for the transient decrease in liver injury during steatosis stage of alcoholic liver disease. Toxicol Pathol (2004) 0.92

Potential health benefits of moderate alcohol consumption: current perspectives in research. Proc Nutr Soc (2012) 0.91

Expression of HSP47, a collagen-specific chaperone, in normal and diseased human liver. Lab Invest (2005) 0.90

Effect of ethanol on polyamine synthesis during liver regeneration in rats. J Clin Invest (1990) 0.85

Cyclin A: function and expression during cell proliferation. Prog Cell Cycle Res (1995) 0.85

Acute ethanol preexposure promotes liver regeneration after partial hepatectomy in mice by activating ALDH2. Am J Physiol Gastrointest Liver Physiol (2013) 0.85

What fires prometheus? The link between inflammation and regeneration following chronic liver injury. Int J Biochem Cell Biol (2007) 0.85

In vivo regulation of the entry into M-phase: initial activation and nuclear translocation of cyclin B/Cdc2. Prog Cell Cycle Res (1997) 0.84

Moderate, chronic ethanol feeding exacerbates carbon-tetrachloride-induced hepatic fibrosis via hepatocyte-specific hypoxia inducible factor 1α Pharmacol Res Perspect (2014) 0.80

Once initiated, how does toxic tissue injury expand? Trends Pharmacol Sci (2012) 0.80